FAMOTIDINE

Product NDC
72603-564
11-digit product format
726030564
Labeler code
72603
Product ID
72603-564_4af90b5d-f47a-4436-8e24-4cb7e5b758b3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
FAMOTIDINE
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Labeler
NorthStar Rx LLC
Application
ANDA219091
Marketing category
ANDA
Marketing start
2026-10-01
Substance
FAMOTIDINE
Active strength
40 mg/5mL
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219091-001FAMOTIDINEFAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2025-07-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A219091-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A219091-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2025-07-09d4dbc9d85df4…
2026-10-15 13:18:302026-09A219091-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2025-07-09c2088c7a36db…
2026-09-14 22:38:342026-08A219091-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2025-07-0984e616aacf4f…
2026-08-18 06:07:402026-07A219091-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2025-07-09caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219091-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2025-07-09011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219091-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2025-07-0931067a03dcf5…
2025-08-23 18:47 UTC2025-08A219091-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2025-07-096a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219091-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2025-07-09a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A219091-001AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A219091-001AB1c2088c7a36db…
2026-09-14 22:38:342026-08A219091-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A219091-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219091-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219091-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A219091-001AB16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219091-001AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
FAMOTIDINE
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
FAMOTIDINE40 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5QZO15J2Z8Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
310274Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4af90b5d-f47a-4436-8e24-4cb7e5b758b3Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FAMOTIDINEFAMOTIDINENorthStar Rx LLC4af90b5d-f47a-4436-8e24-4cb7e5b758b32026-08-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219091
application number: ANDA219091
ndc (product): 72603-564
FAMOTIDINEFAMOTIDINEAurobindo Pharma Limited18066b80-1ec6-4092-80d9-70adb0ecac852026-01-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219091
application number: ANDA219091

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
72603-564-017260305640150 mL in 1 BOTTLE (72603-564-01) 50 ml2026-10-01NoNoCurrent